'Buprenorphine naloxone' diaporamas de présentation

Update on Alcohol, Other Drugs, and Health

711 views • 71 slides

ORAL SUBSTITUTION WITH BUPRENORPHINE Anju Dhawan Associate Professor

ORAL SUBSTITUTION WITH BUPRENORPHINE Anju Dhawan Associate Professor National Drug Dependence Treatment Centre AIIMS. Contents. History and Milestones Experience: Research and Clinical The Future. Contents. History and Milestones Our Experience: Clinical and Research The Future.

557 views • 44 slides

Medication Assisted Treatment for Polysubstance Users who have Opioid Use Disorder

Medication Assisted Treatment for Polysubstance Users who have Opioid Use Disorder. University of Louisville CAPTASA 2019 Embassy Suites, Lexington, Kentucky January 25, 2019 Quintin T. Chipley, M.A., M.D., Ph.D. DISCLOSURES.

419 views • 41 slides

Outline of presentation

Opioid Substitution Therapy (OST) toolkits: Advocacy for a scaled-up OST programme in the region Dr M Suresh Kumar. Outline of presentation. Model of integrated OST and HIV care: evidence Current status of OST in Asia: the response in the region Gaps in response: Opportunity for improvement

482 views • 37 slides

So You Prescribed Suboxone : Do Patients Really Take It?

So You Prescribed Suboxone : Do Patients Really Take It?. Discussion of Patient A dherence to Suboxone / Burprenorphine Regimens. Teresa Hudson, PharmD , PhD Associate Professor, Department of Psychiatry. CE Credits: TEXT: 501-406-0076 Activity Code: 29473-24581. NO Disclosures.

363 views • 25 slides

Conclusions

Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid -dependent youth: Secondary analyses from a NIDA Clinical Trials Network Study RD Weiss a,b , A Chakrabarti a,b , GE Woody c , ML Griffin a,b , G Subramaniam d , DR Dodd a

111 views • 1 slides